1Michel Goedert. A century of Alzheimer's disease [J]. Science, 2006,314 : 777 - 781.
2Mark A, Findeis. The role of amyloid β peptide 42 in Alzheimer' s disease [ J ]. Pharmacology & Therapeutics, 2007,116 : 266 - 286.
3Schenk D, Barbour R, DunnW, et al. Immunization with amyloid-β attenuates Alzheimer's disease-like pathology in the PDAPP mouse [J]. Nature, 1999,400 : 173 - 177.
4Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta peptide enter the central nervous system and reduce pathology in a mouse mode of Alzheimer disease [J].NatMed,2000,6:916 - 920.
5Schenk E. Nerve inflammation halts trial for Alzheimersp drug [ J]. Nature, 2002,415 : 462.
6Alon M, Ruth M, Victor Z, et al. Immune hyporesponsiveness to amyloid β peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimers disease [J].Proc Natl Acad Sci USA,2001,98 (18) : 10273 - 10278.
7Mason HS,Lam DMK,Arntzen CJ, et al.Expression of hepatitis B surface antigen in transgenic plants [J] .Proc Natl Acad Sci USA, 1992,89 : 11745 - 11749.
8D. E. Webster, M. C. Thomas, Z Huang, et al. The development of a plant-based vaccine for measles[J]. Vaccine ,2005, 23 : 1859 - 1865.
9Henry Daniell. Expression of the nNative cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts[J] .J Mol Biol,2001,311:1001- 1009.
10Kim H S, Euym J W. Expression of human amyloid-β pepfide in transgenic potato[J]. Plant Sci, 2003,165 : 1445 - 1451.
